Algal Research

To many people, the term seaweeds refers to the yucky brown or green stuff that sticks to your legs at the beach. To others, however, it means big business, and to some researchers, seaweeds equals big science. Marine biologist Thierry Chopin, University of New Brunswick in St. John, Canada, citing United Nations statistics, says that in 1998, 21.7 percent of the 39.4 million metric tons of aquaculture products sold worldwide consisted of seaweeds, totaling $5.9 billion. Moreover, seaweeds accou

Written byMyrna Watanabe
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Seaweeds are excellent sources of polysaccharides. Commercially, seaweed extracts produce the food thickener carrageenan, agar for food and biological research uses, docosahexaenoic acid, fertilizer, vitamins, and other products. One of the most profitable marine aquaculture products is nori (the red alga Porphyra), used for wrapping the near-ubiquitous sushi. This market exceeds $1.61 billion a year.

More reasons exist to grow seaweed than just profit from seaweed itself. Aquaculture is growing in popularity, as evidence accumulates that the ocean alone cannot supply enough finfish, crustaceans, and mollusks to the world. But with fish farming comes pollution, especially increases in nitrogen and phosphorus. Seaweeds can help control these byproducts. Christina Halling, a doctoral student in the department of systems ecology at Stockholm University, Sweden, explains, "In an intensive salmon farm, less than one-third of the added nutrients [provided] through feed is removed through the fish harvest. Two-thirds of the nutrients are released ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies